ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,896Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 1442

$353K Total Retail Price of All Prescriptions

Rank: 237 out of 1442

346 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 346 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

4% of this provider’s 7,871 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
CLONIDINE HCL 794 609 1 66
FUROSEMIDE 502 374 2 5
LISINOPRIL 481 366 3 7
METOPROLOL TARTRATE 449 350 4 6
AMLODIPINE BESYLATE 422 308 5 3
HYDROCODONE-ACETAMINOPHEN 311 253 S3 6 84
ATORVASTATIN CALCIUM 301 266 7 4
QUINAPRIL HCL 260 210 8 42
CARVEDILOL 245 168 9 8
HYDROCHLOROTHIAZIDE 242 211 10 16
BUSPIRONE HCL 235 192 11 165
OMEPRAZOLE 218 183 12 21
DIOVAN 173 144 13 19
HYDRALAZINE HCL 165 143 14 48
LOVASTATIN 144 128 15 53
ZOLPIDEM TARTRATE 141 108 16 25
ISOSORBIDE MONONITRATE ER 131 76 17 17
CLOPIDOGREL 116 91 18 12
VERAPAMIL ER 111 99 19 77
WARFARIN SODIUM 107 84 20 9
DILTIAZEM HCL 102 78 21 159
LEVOTHYROXINE SODIUM 99 86 22 22
LIPITOR 97 82 23 24
ACETAMINOPHEN-CODEINE 94 80 S3 24 168
CIPROFLOXACIN HCL 94 65 24 103
METFORMIN HCL 89 66 26 26
GLYBURIDE 86 80 R 27 105
EXFORGE 84 74 28 80
GLYBURIDE-METFORMIN HCL 80 68 R 29 121
KLOR-CON M20 78 64 30 72
NITROSTAT 78 66 30 44
PLAVIX 77 60 32 14
POTASSIUM CHLORIDE 74 68 33 33
METOPROLOL SUCCINATE 71 47 34 1
NEXIUM 71 51 34 34
CRESTOR 70 65 36 10
METHOCARBAMOL 69 50 R 37 312
ALLOPURINOL 69 68 37 47
NIFEDIPINE ER 68 68 39 39
AMLODIPINE BESYLATE-BENAZEPRIL 66 59 40 43
NIFEDICAL XL 62 51 41 140
METOCLOPRAMIDE HCL 61 58 42 197
NITROGLYCERIN PATCH 61 49 42 65
GABAPENTIN 58 58 44 55
IBUPROFEN 57 42 45 130
RAMIPRIL 56 39 46 18
LABETALOL HCL 55 48 47 75
HYDROCORTISONE 54 39 48 346
INDAPAMIDE 53 41 49 122
SIMVASTATIN 53 29 49 2
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.